Virus-like particles (VLPs) are nanostructures that possess diverse applications in
therapeutics, immunization, and diagnostics. With the recent advancements in biomedical …

Nanotechnology is a fast-evolving field focused on fabricating nanoscale objects for
industrial, cosmetic, and therapeutic applications. Virus-like particles (VLPs) are self …

Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use
of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human …

The capsid proteins of many viruses are capable of spontaneous self-assembly into virus-
like particles (VLPs), which do not contain the viral genome and are therefore not infectious …

Vaccines for human use have conventionally been developed by the production of (1)
microbial pathogens in eggs or mammalian cells that are then inactivated, or (2) by the …

As the world continues to battle the COVID-19 pandemic and the pig farming sector is
concerned with the relentless geographical spread of African Swine Fever, another serious …

African horse sickness (AHS) is a devastating equine infectious disease. On 17 March 2020,
it first appeared in Thailand and threatened all the South-East Asia equine industry security …

Emerging and re-emerging zoonotic diseases cause serious illness with billions of cases,
and millions of deaths. The most effective way to restrict the spread of zoonotic viruses …

A safe, highly immunogenic multivalent vaccine to protect against all nine serotypes of
African horse sickness virus (AHSV), will revolutionise the AHS vaccine industry in endemic …

Bluetongue virus (BTV) and African horse sickness virus (AHSV) are widespread
arboviruses that cause important economic losses in the livestock and equine industries …